Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exact Sciences

48.78
+1.232.59%
Post-market: 47.50-1.2800-2.62%19:17 EST
Volume:3.66M
Turnover:177.01M
Market Cap:9.06B
PE:-8.73
High:49.52
Open:46.66
Low:45.80
Close:47.55
Loading ...

Company Profile

Company Name:
Exact Sciences
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
6950
Office Location:
5505 Endeavor Lane,Madison,Wisconsin,United States
Zip Code:
53719
Fax:
- -
Introduction:
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Directors

Name
Position
Kevin T. Conroy
President, Chief Executive Officer and Chairman of the Board
David A. Thompson
Lead Independent Director
Maneesh K. Arora
Senior Vice President, Chief Operating Officer and Director
Daniel J. Levangie
Director
James E. Doyle
Director
John A. Fallon
Director
Katherine S. Napier
Director
Lionel N. Sterling
Director
Michael S. Wyzga
Director
Thomas D. Carey
Director

Shareholders

Name
Position
Kevin T. Conroy
President, Chief Executive Officer and Chairman of the Board
Maneesh K. Arora
Senior Vice President, Chief Operating Officer and Director
D. Scott Coward
Senior Vice President, General Counsel and Secretary
Graham P. Lidgard
Senior Vice President and Chief Science Officer
Jeffrey T. Elliott
Chief Financial Officer